BDS
ELV icon

Banco de Sabadell’s Elevance Health ELV Stock Holding History

Banco de Sabadell’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,362
Closed -$9.6M – 182
2021
Q1 		$9.6M Sell
26,362
-8,441
-24% -$2.71M 0.99% 29
2020
Q4 		$11M Buy
34,803
+14,513
+72% +$4.45M 1.16% 20
2020
Q3 		$5.31M Hold
20,290
– – 0.6% 41
2020
Q2 		$5.3M Buy
20,290
+5,343
+36% +$1.43M 0.69% 38
2020
Q1 		$3.42M Buy
+14,947
New +$4.07M 0.54% 54
2018
Q2 		– Sell
-5,878
Closed -$1.3M – 417
2018
Q1 		$1.3M Buy
+5,878
New +$1.38M 0.16% 145

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Banco de Sabadell's ELV Position: Q2 2021 in Review

Banco de Sabadell sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 26,362 shares — an estimated $9.6M sold.

Banco de Sabadell first reported a position in ELV in Q1 2018 and held it in 6 quarters. The position peaked at $11M in Q4 2020. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • Banco de Sabadell reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • Banco de Sabadell sold 26,362 Elevance Health shares in Q2 2021, an estimated $9.6M.
  • Banco de Sabadell first reported a position in Elevance Health in Q1 2018 and held it in 6 quarters.
  • Banco de Sabadell's Elevance Health position peaked at $11M in Q4 2020.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Banco de Sabadell's 13F filing for Q2 2021, filed 13 Aug 2021.